Literature DB >> 7521976

HLA-B15: a widespread and diverse family of HLA-B alleles.

W H Hildebrand1, J D Domena, S Y Shen, M Lau, P I Terasaki, M Bunce, S G Marsh, M G Guttridge, W B Bias, P Parham.   

Abstract

HLA-B15 embraces a multiplicity of antigenic specificities which vary in their distribution amongst human populations. To correlate B15 molecular structure with the serological picture we have sequenced alleles encoding the various subspecificities of the B15 antigen: B62, B63, B75, B76 and B77, and a number of "variants" of these antigens including the 8w66 split of B63. HLA-B63 (B*1517) and 8w66 (B*1516) heavy chains have sequence identity to B17 in the alpha 1 helix correlating with the antigenic crossreactivity of these molecules. HLA-B77(B*1513) and B75 (B*1502) heavy chains differ solely in segments determining the Bw4 and Bw6 public epitopes, consistent with the serological description of the B77 and B75 antigens. One allele encoding the B76 antigen (B*1512) appears to be the product of gene conversion between the HLA-A and -B loci and differs from B*1501 in codons 166 and 167. In contrast, a second allele encoding the B76 antigen (B*1514) differs from B*1501 by an unrelated substitution in codon 167 which confers similarily with B45, an antigen crossreactive with B76. A third allele encoding B76, B*1519, differs from B*1512 by a unique point substitution in exon 4. Three alleles encoding variant B15 and B62 antigens (B*1508, B*1511 and B*1515) differ from B*1501 by localized clusters of substitutions that probably result from interallelic conversion. The B15 sequences described in this paper, in combination with those previously determined, define a family of 22 alleles, including those encoding the B46 and B70 antigens. Within this family the patterns of allelic substitution are analogous to those of other HLA-A and -B families, in that pairwise differences almost always involve functional positions of the antigen recognition site and recombination is the major agent of diversification.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7521976     DOI: 10.1111/j.1399-0039.1994.tb02327.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  11 in total

1.  A structurally based approach to determine HLA compatibility at the humoral immune level.

Authors:  Rene J Duquesnoy
Journal:  Hum Immunol       Date:  2006-09-01       Impact factor: 2.850

2.  The nature of peptides presented by an HLA class I low expression allele.

Authors:  Jan Hinrichs; Daniel Föll; Christina Bade-Döding; Trevor Huyton; Rainer Blasczyk; Britta Eiz-Vesper
Journal:  Haematologica       Date:  2010-03-10       Impact factor: 9.941

3.  HLA Correlations with Clinical Phenotypes and Risk of Metabolic Comorbidities in Singapore Chinese Psoriasis Patients.

Authors:  Meixin Shen; Soon Wei Daniel Lim; Eugene S Tan; Hazel H Oon; Ee Chee Ren
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

4.  HLA-B alleles of the Cayapa of Ecuador: new B39 and B15 alleles.

Authors:  T L Garber; L M Butler; E A Trachtenberg; H A Erlich; O Rickards; G De Stefano; D I Watkins
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

5.  Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes.

Authors:  Isobella Honeyborne; Andrew Prendergast; Florencia Pereyra; Alasdair Leslie; Hayley Crawford; Rebecca Payne; Shabashini Reddy; Karen Bishop; Eshia Moodley; Kriebashnie Nair; Mary van der Stok; Noel McCarthy; Christine M Rousseau; Marylyn Addo; James I Mullins; Christian Brander; Photini Kiepiela; Bruce D Walker; Philip J R Goulder
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

6.  Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity.

Authors:  Michal Bassani-Sternberg; Chloé Chong; Philippe Guillaume; Marthe Solleder; HuiSong Pak; Philippe O Gannon; Lana E Kandalaft; George Coukos; David Gfeller
Journal:  PLoS Comput Biol       Date:  2017-08-23       Impact factor: 4.475

7.  Specific amino acid patterns define split specificities of HLA-B15 antigens enabling conversion from DNA-based typing to serological equivalents.

Authors:  Burcu Duygu; Benedict M Matern; Lotte Wieten; Christina E M Voorter; Marcel G J Tilanus
Journal:  Immunogenetics       Date:  2020-06-20       Impact factor: 2.846

8.  Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA.

Authors:  J A McCutcheon; J Gumperz; K D Smith; C T Lutz; P Parham
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

9.  The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.

Authors:  J E Gumperz; V Litwin; J H Phillips; L L Lanier; P Parham
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

10.  HLA-B*15 predicts survival in Egyptian patients with COVID-19.

Authors:  Ahmed Samir Abdelhafiz; Asmaa Ali; Merhan A Fouda; Douaa M Sayed; Mahmoud M Kamel; Lamyaa Mohamed Kamal; Mahmoud Ali Khalil; Rania M Bakry
Journal:  Hum Immunol       Date:  2021-09-27       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.